Skip to main content

Table 21 Anti-TMV activities of titled compounds at 500 μg/mL in vivo [1]

From: Therapeutic potential of oxadiazole or furadiazole containing compounds

Compounds

Rate (%)

Compounds

Rate (%)

Curative activity

Protective activity

Curative activity

Protective activity

40

38.5 ± 1.2

35.2 ± 3.1

448

60.0 ± 5.6

36.4 ± 1.0

41

36.9 ± 5.1

14.4 ± 2.9

449

26.9 ± 2.9

43.3 ± 3.0

42

26.8 ± 5.2

54.5 ± 2.9

4410

48.7 ± 5.1

25.2 ± 2.9

43a

22.3 ± 6.4

54.6 ± 5.2

4415

51.9 ± 3.0

45.6 ± 4.2

43b

47.2 ± 2.8

38.8 ± 4.5

40’

41.8 ± 1.0

41.7 ± 1.7

43c

44.8 ± 9.5

36.8 ± 0.8

41’

17.5 ± 1.2

32.2 ± 1.6

444

7.1 ± 1.7

51.2 ± 7.6

42’

17.7 ± 1.2

42.6 ± 2.2

445

37.4 ± 3.5

27.8 ± 5.5

432’

49.3 ± 2.0

19.6 ± 2.4

446

50.6 ± 4.7

42.9 ± 2.5

4410’

33.9 ± 1.3

20.2 ± 1.0

447

37.1 ± 3.3

23.5 ± 1.1

4415’

35.3 ± 2.3

19.3 ± 0.8

NNM

54.2 ± 2.9

65.7 ± 2.2

  Â